![](https://attraxcdnprod1-freshed3dgayb7c3.z01.azurefd.net/1481078/891f3803-db1b-4640-d2fa-08d55bf88b78/2022.14683-2022.2-rc/img/Gzqk2rTAeUA8SAjbCMTzIw/Case+studies+-+white+square+for+blogs.png?v=e84eb721e7e66b97d6c0aacec24a4bf4)
MAKING DECISIONS AS A LEADER | HELEN YUANYUAN CAO 鈥 CHIEF OPERATING OFFICER AND CHIEF INNOVATION OFFICER AT INDICAL BIOSCIENCE | LIFE SCIENCE LEADERS' SERIES
In the fourth part of our Life Science Leadership series, 探花合集 Staffing Associate Director, Precision Medicine, Naima Morys, chats to Helen Yuanyuan Cao, Chief Operating Officer and Chief Innovation Officer at Bioscience. They discuss how to make balanced decisions as a life science leader and the importance of communicating a clear vision.
Before joining Bioscience, Helen was a member of the EMEA Management Team at BD Biosciences, the immunology diagnostics part of Becton Dickinson, a fortune 500 global medical technology and diagnostics company. Helen built Advanced Analytics at McKesson and was in multiple roles in bioinformatics, innovation, and strategy at Qiagen before embarking on her career in management consulting at Bain & Company.
For years, Helen has been a mentor of various start-ups and has been on the board of the Make-A-Wish Foundation, Germany, and volunteered at future.coop, a social startup in the field of sustainability.
She is a lecturer at multiple universities on the topics of innovation and leadership and is on the advisory board of the MBA program Digital Management & Marketing at the University of N眉rningen-Geislingen. A proven industry leader, Helen has been named 鈥40 under 40鈥 by Germany鈥檚 top business magazine Capital for three years and 鈥淩ising Talent鈥 by the Women鈥檚 Forum for the Economy and Society. She was also awarded 鈥淢anager of the Year鈥 by GenerationCEO.